Literature DB >> 29171132

Structured education to improve primary-care management of headache: how long do the benefits last? A follow-up observational study.

M Braschinsky1,2, S Haldre1,2, M Kals3, M Arge4, B Saar4, M Niibek4, Z Katsarava5, T J Steiner6,7.   

Abstract

BACKGROUND AND
PURPOSE: Our earlier study showed that structured education of general practitioners (GPs) improved their practice in headache management. Here the duration of this effect was assessed.
METHODS: In a follow-up observational study in southern Estonia, subjects were the same six GPs as previously, managing patients presenting with headache as the main complaint. Data reflecting their practice were collected prospectively during a 1-year period commencing 2 years after the educational intervention. The primary outcome measure was referral rate (RR) to neurological services. Comparisons were made with baseline and post-intervention data from the earlier study.
RESULTS: In 366 patients consulting during the follow-up period, the RR was 19.9%, lower than at baseline (39.5%; P < 0.0001) or post-intervention (34.7%; P < 0.0001). The RR was diagnosis-dependent: the biggest decline was for migraine. Use of headache diagnostic terms showed changes generally favouring specific terminology. In particular, the proportion of patients given migraine diagnoses greatly increased whilst use of the inappropriate M79.1 (Pericranial) myalgia almost disappeared. Requests for investigations, which had fallen from 26% (of patients seen) at baseline to 4% post-intervention, resurged to 23% (mostly laboratory investigations; requests for X-rays continued to dwindle). Initiation of treatment by the GPs remained at the post-intervention level of just over 80% (up from baseline 58%).
CONCLUSIONS: Improvements in GPs' practice after a structured educational programme mostly last for ≥3 years, some showing further betterment. A few measures suggest the beginnings of a decline towards baseline levels. This policy-informing evidence for continuing medical education indicates that the educational programme needs repeating every 2-3 years.
© 2017 EAN.

Entities:  

Keywords:  continuing medical education; duration of effect; effect measurement; global campaign against headache; headache disorders; management; policy; primary care

Mesh:

Year:  2017        PMID: 29171132     DOI: 10.1111/ene.13524

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  4 in total

1.  Headache service quality evaluation: implementation of quality indicators in primary care in Europe.

Authors:  B Lenz; Z Katsarava; R Gil-Gouveia; G Karelis; B Kaynarkaya; L Meksa; E Oliveira; F Palavra; I Rosendo; M Sahin; B Silva; D Uludüz; Y Z Ural; I Varsberga-Apsite; S T Zengin; L Zvaune; T J Steiner
Journal:  J Headache Pain       Date:  2021-04-28       Impact factor: 7.277

Review 2.  The Global Campaign turns 18: a brief review of its activities and achievements.

Authors:  Timothy J Steiner; Gretchen L Birbeck; Rigmor H Jensen; Paolo Martelletti; Lars Jacob Stovner; Derya Uluduz; Matilde Leonardi; Jes Olesen; Zaza Katsarava
Journal:  J Headache Pain       Date:  2022-04-21       Impact factor: 8.588

3.  The Headache-Attributed Lost Time (HALT) Indices: measures of burden for clinical management and population-based research.

Authors:  T J Steiner; R B Lipton
Journal:  J Headache Pain       Date:  2018-02-02       Impact factor: 7.277

4.  Structured headache services as the solution to the ill-health burden of headache: 1. Rationale and description

Authors:  Timothy J Steiner; Rigmor Jensen; Zaza Katsarava; Lars Jacob Stovner; Derya Uluduz; Latifa Adarmouch; Mohammed Al Jumah; Ali M Al Khathaami; Messoud Ashina; Mark Braschinsky; Susan Broner; Jon H Eliasson; Raquel Gil-Gouveia; Juan B Gómez-Galván; Larus S Gudmundsson; Akbar A Herekar; Nfwama Kawatu; Najib Kissani; Girish Baburao Kulkarni; Elena R Lebedeva; Matilde Leonardi; Mattias Linde; Otgonbayar Luvsannorov; Youssoufa Maiga; Ivan Milanov; Dimos D Mitsikostas; Teymur Musayev; Jes Olesen; Vera Osipova; Koen Paemeleire; Mario F P Peres; Guiovanna Quispe; Girish N Rao; Ajay Risal; Elena Ruiz de la Torre; Deanna Saylor; Mansoureh Togha; Sheng-Yuan Yu; Mehila Zebenigus; Yared Zenebe Zewde; Jasna Zidverc-Trajković; Michela Tinelli
Journal:  J Headache Pain       Date:  2021-07-21       Impact factor: 7.277

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.